Abstract: A computer controlled apparatus for detecting breast tumors by mechanically palpating in a full surface scan manner to detect even very small lumps or other anomalies. The patient is positioned on a fully adjustable bed and oriented relative the apparatus. A detection head mounted for movement in three dimensions is positioned above the bed. A palpation finger is brought into pressure contact with a sequence of small areas across the entire breast, palpating each area to measure tissue density. Concurrent with the palpation scan, a scan of breast color and temperature is conducted. A locator head positions the detector for the scan in a manner that assures repeatability of the palpation scan during each of a series of periodic examinations. This system detects very small lumps and allows easy, accurate, monitoring of suspicious areas over an extended time period.
Abstract: A novel gene, DDM1, and its encoded protein are provided. The gene was isolated from a region of Arabidopsis thaliana chromosome 5. DDM1 appears to be part of the SWI2/SNF2 family of chromatin-remodeling proteins. Disruption of the gene results in DNA hypomethylation, among other phenotypes. The DDM1 gene defines a novel member of the DNA methylation system. Methods of using DDM1, and transgenic organisms comprising DDM1, are also provided.
Abstract: An isolated nucleic acid from the bacterium Thermotoga neapolitana, encoding a thermostable .alpha.-galactosidase is provided. The Thermotoga gene is cloned into a high expression vector to provide large quantities of a purified thermostable .alpha.-galactosidase. The thermostable enzyme is used in high-temperature processing of soy products to remove .alpha.-galactosides.
Type:
Grant
Filed:
August 21, 1998
Date of Patent:
November 21, 2000
Assignees:
Rutgers, The State University of New Jersey, The Board of Trustees of the University of Illinois
Inventors:
Dinesh Yernool, Douglas E. Eveleigh, Michael R. King, Bruce Chassy
Abstract: A method is described for the creation of novel isoforms of the enzyme glutathione S-transferase which have enhanced activity in host cells against specific toxic agents. The method includes site directed mutagenesis and selection with the targeted agent in the host cells. The sites of directed mutagenesis is the site of electrophile binding by the native form of the enzyme. This site has proven susceptible to manipulation without loss of enzymatic activity. Various techniques for enhancing the expression, activity, or localization of the expressed enzyme in mammalian cells are described. Genes for the mutant isoforms of the enzyme may be useful in cancer therapeutics to confer upon selected groups of cells heightened resistance to antineoplastic agents.
Type:
Grant
Filed:
August 26, 1994
Date of Patent:
October 24, 2000
Assignee:
Wisconsin Alumni Research Foundation
Inventors:
William E. Fahl, Andrew M. Gulick, T. Herbert Manoharan, Ralph B. Puchalski, Katharine Kramer, Wyeth W. Wasserman